Key result
Stage 2 systolic blood pressure is linked to ~11-fold higher odds of high 10-year CVD risk.
Why the study?
The study was conducted to assess the level of cardiovascular disease risk and associated factors among hypertensive patients having follow-up at selected hospitals in Addis Ababa, Ethiopia.
Does stage 2 systolic blood pressure increase the predicted 10-year cardiovascular disease risk in hypertensive patients?
Cross-Sectional (n=326)
Yes
Does stage 2 systolic blood pressure increase the predicted 10-year cardiovascular disease risk in hypertensive patients?
Odds Ratio: 11.32 (95% CI 3.43–37.46)
p-value: p=<0.05
A significant proportion of hypertensive patients in Ethiopia have a high 10-year CVD risk, strongly driven by uncontrolled systolic blood pressure.
Uncontrolled stage 2 SBP flags high predicted CVD risk in hypertensives; leaves open whether targeting it improves outcomes.
OBJECTIVE: The aim of this study was to assess the level of cardiovascular disease (CVD) risk and associated factors among hypertensive patients having follow-up at selected hospitals in Addis Ababa, Ethiopia, in 2022. SETTING: A hospital-based cross-sectional study was conducted in public and tertiary hospitals in Addis Ababa, Ethiopia, from 15 January 2022 to 30 July 2022. PARTICIPANTS: A total of 326 adult hypertensive patients who visited the chronic diseases clinic for follow-up were included in the study. PRIMARY AND SECONDARY OUTCOME MEASURES: A high predicted 10-year CVD risk level was assessed using an interviewer-administered questionnaire and physical measurement (primary data) and reviews of medical data records (secondary data) by using a non-laboratory WHO risk prediction chart. Logistic regression with an adjusted OR (AOR) using a 95% CI was calculated for independent variables associated with 10-year CVD risk. RESULTS: The prevalence of a high predicted 10-year CVD risk level was 28.2% (95% CI 10.34% to 33.2%) among the study participants. A higher CVD risk level was found to be associated with age (AOR 4.2 for age 64-74, 95% CI 1.67 to 10.66), being male (AOR 2.1, 95% CI 1.18, 3.67), unemployment (AOR 3.2, 95% CI 1.06 to 6.25) and stage 2 systolic blood pressure (AOR 11.32; 95% CI 3.43 to 37.46). CONCLUSION: The study showed that the respondent's age, gender, occupation and high systolic blood pressure were determinant factors for CVD risks. Therefore, routine screening for the presence of CVD risk factors and assessment of CVD risk are recommended for hypertensive patients for CVD risk reduction.
No takes yet. Share an insight, caveat, or question.
Getahun et al. (2023) conducted a cross-sectional in Hypertension (n=326). Stage 2 systolic blood pressure vs. Systolic blood pressure <120 mm Hg was evaluated on High predicted 10-year CVD risk level (>10%) using non-laboratory WHO risk prediction chart (AOR 11.32, 95% CI 3.43-37.46, p=<0.05). Stage 2 systolic blood pressure was associated with an 11-fold increased odds of high 10-year cardiovascular disease risk among hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: